Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study.

CONCLUSIONS: The Cardiff Model of Glaucoma Care offers novel clinical and adherence insights at marginal costs while acceptable to patients. Healthcare professionals felt that 4 hour and 4 week follow-up appointments could cause administrative problems. A streamlined version of the pathway has therefore been developed to facilitate clinical adoption. TRIAL REGISTRATION NUMBER: ISRCTNID:ISRCTN75888393. PMID: 32139500 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32139500?dopt=Abstract

Source: The British Journal of Ophthalmology - March 3, 2020 Category: Opthalmology Authors: Waterman H, Read S, Morgan JE, Gillespie D, Nollett C, Allen D, Weiss M, Anderson P Tags: Br J Ophthalmol Source Type: research